BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
DTSTART:19810329T020000
TZNAME:MESZ
TZOFFSETTO:+0200
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
DTSTART:19961027T030000
TZNAME:MEZ
TZOFFSETTO:+0100
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
CREATED:20180912T154608Z
TRANSP:OPAQUE
X-APPLE-TRAVEL-ADVISORY-BEHAVIOR:AUTOMATIC
UID:TYPO320261030
DTSTAMP:20261030T121000Z
DTSTART;TZID=Europe/Berlin:20261030T121000
DTEND;TZID=Europe/Berlin:20261030T131000
SUMMARY:Ultra-long-acting bei CRSwNP: Wenn das Dosierungsintervall den Unterschied macht
DESCRIPTION:Sven Becker (Tübingen)
Andreas Horn (Heidelberg)
Pascal Werminghaus (Düsseldorf)Sven Becker (Tübingen)GlaxoSmithKline GmbH & Co. KG
LOCATION:Musensaal
SEQUENCE:0
END:VEVENT
END:VCALENDAR